Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Brazil Temperature Controlled Packaging Pharmaceutical Market

ID: MRFR/PCM/55284-HCR
200 Pages
Snehal Singh
Last Updated: February 06, 2026

Brazil Temperature Controlled Packaging Pharmaceutical Market Research Report By Product (Shippers, Containers), By Type (Active System, Passive System), By Temperature Range (-20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, Above 25°C), By Payload Capacity (Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, Above 150 L), By Use (Single Use, Reusable), By Medicine Type (Temperature Sensitive Pharmaceutical Drugs, Vaccine, Regenerative Medicine) andBy End-use Industry (Pharmaceuticals, Clinical Trails)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Brazil Temperature Controlled Packaging Pharmaceutical Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Packaging & Transport, BY Product (USD Million)
  49.     4.1.1 Shippers
  50.     4.1.2 Containers
  51.   4.2 Packaging & Transport, BY Type (USD Million)
  52.     4.2.1 Active System
  53.     4.2.2 Passive System
  54.   4.3 Packaging & Transport, BY Temperature Range (USD Million)
  55.     4.3.1 -20°C and Below
  56.     4.3.2 -20°C to 0°C
  57.     4.3.3 2°C to 8°C
  58.     4.3.4 8°C to 25°C
  59.     4.3.5 Above 25°C
  60.   4.4 Packaging & Transport, BY Payload Capacity (USD Million)
  61.     4.4.1 Up to 10 L
  62.     4.4.2 10 L - 20 L
  63.     4.4.3 20 L - 40 L
  64.     4.4.4 40 L - 150 L
  65.     4.4.5 Above 150 L
  66.   4.5 Packaging & Transport, BY Use (USD Million)
  67.     4.5.1 Single Use
  68.     4.5.2 Reusable
  69.   4.6 Packaging & Transport, BY Medicine Type (USD Million)
  70.     4.6.1 Temperature Sensitive Pharmaceutical Drugs
  71.     4.6.2 Vaccine
  72.     4.6.3 Regenerative Medicine
  73.   4.7 Packaging & Transport, BY End-use Industry (USD Million)
  74.     4.7.1 Pharmaceuticals
  75.     4.7.2 Clinical Trials
  76. 5 SECTION V: COMPETITIVE ANALYSIS
  77.   5.1 Competitive Landscape
  78.     5.1.1 Overview
  79.     5.1.2 Competitive Analysis
  80.     5.1.3 Market share Analysis
  81.     5.1.4 Major Growth Strategy in the Packaging & Transport
  82.     5.1.5 Competitive Benchmarking
  83.     5.1.6 Leading Players in Terms of Number of Developments in the Packaging & Transport
  84.     5.1.7 Key developments and growth strategies
  85.       5.1.7.1 New Product Launch/Service Deployment
  86.       5.1.7.2 Merger & Acquisitions
  87.       5.1.7.3 Joint Ventures
  88.     5.1.8 Major Players Financial Matrix
  89.       5.1.8.1 Sales and Operating Income
  90.       5.1.8.2 Major Players R&D Expenditure. 2023
  91.   5.2 Company Profiles
  92.     5.2.1 Thermo Fisher Scientific (US)
  93.       5.2.1.1 Financial Overview
  94.       5.2.1.2 Products Offered
  95.       5.2.1.3 Key Developments
  96.       5.2.1.4 SWOT Analysis
  97.       5.2.1.5 Key Strategies
  98.     5.2.2 Sonoco Products Company (US)
  99.       5.2.2.1 Financial Overview
  100.       5.2.2.2 Products Offered
  101.       5.2.2.3 Key Developments
  102.       5.2.2.4 SWOT Analysis
  103.       5.2.2.5 Key Strategies
  104.     5.2.3 Pelican BioThermal (US)
  105.       5.2.3.1 Financial Overview
  106.       5.2.3.2 Products Offered
  107.       5.2.3.3 Key Developments
  108.       5.2.3.4 SWOT Analysis
  109.       5.2.3.5 Key Strategies
  110.     5.2.4 CSafe Global (US)
  111.       5.2.4.1 Financial Overview
  112.       5.2.4.2 Products Offered
  113.       5.2.4.3 Key Developments
  114.       5.2.4.4 SWOT Analysis
  115.       5.2.4.5 Key Strategies
  116.     5.2.5 DHL Supply Chain (DE)
  117.       5.2.5.1 Financial Overview
  118.       5.2.5.2 Products Offered
  119.       5.2.5.3 Key Developments
  120.       5.2.5.4 SWOT Analysis
  121.       5.2.5.5 Key Strategies
  122.     5.2.6 Cold Chain Technologies (US)
  123.       5.2.6.1 Financial Overview
  124.       5.2.6.2 Products Offered
  125.       5.2.6.3 Key Developments
  126.       5.2.6.4 SWOT Analysis
  127.       5.2.6.5 Key Strategies
  128.     5.2.7 Envirotainer (SE)
  129.       5.2.7.1 Financial Overview
  130.       5.2.7.2 Products Offered
  131.       5.2.7.3 Key Developments
  132.       5.2.7.4 SWOT Analysis
  133.       5.2.7.5 Key Strategies
  134.     5.2.8 Sofrigam (FR)
  135.       5.2.8.1 Financial Overview
  136.       5.2.8.2 Products Offered
  137.       5.2.8.3 Key Developments
  138.       5.2.8.4 SWOT Analysis
  139.       5.2.8.5 Key Strategies
  140.     5.2.9 Cryopak (US)
  141.       5.2.9.1 Financial Overview
  142.       5.2.9.2 Products Offered
  143.       5.2.9.3 Key Developments
  144.       5.2.9.4 SWOT Analysis
  145.       5.2.9.5 Key Strategies
  146.   5.3 Appendix
  147.     5.3.1 References
  148.     5.3.2 Related Reports
  149. 6 LIST OF FIGURES
  150.   6.1 MARKET SYNOPSIS
  151.   6.2 BRAZIL MARKET ANALYSIS BY PRODUCT
  152.   6.3 BRAZIL MARKET ANALYSIS BY TYPE
  153.   6.4 BRAZIL MARKET ANALYSIS BY TEMPERATURE RANGE
  154.   6.5 BRAZIL MARKET ANALYSIS BY PAYLOAD CAPACITY
  155.   6.6 BRAZIL MARKET ANALYSIS BY USE
  156.   6.7 BRAZIL MARKET ANALYSIS BY MEDICINE TYPE
  157.   6.8 BRAZIL MARKET ANALYSIS BY END-USE INDUSTRY
  158.   6.9 KEY BUYING CRITERIA OF PACKAGING & TRANSPORT
  159.   6.10 RESEARCH PROCESS OF MRFR
  160.   6.11 DRO ANALYSIS OF PACKAGING & TRANSPORT
  161.   6.12 DRIVERS IMPACT ANALYSIS: PACKAGING & TRANSPORT
  162.   6.13 RESTRAINTS IMPACT ANALYSIS: PACKAGING & TRANSPORT
  163.   6.14 SUPPLY / VALUE CHAIN: PACKAGING & TRANSPORT
  164.   6.15 PACKAGING & TRANSPORT, BY PRODUCT, 2024 (% SHARE)
  165.   6.16 PACKAGING & TRANSPORT, BY PRODUCT, 2024 TO 2035 (USD Million)
  166.   6.17 PACKAGING & TRANSPORT, BY TYPE, 2024 (% SHARE)
  167.   6.18 PACKAGING & TRANSPORT, BY TYPE, 2024 TO 2035 (USD Million)
  168.   6.19 PACKAGING & TRANSPORT, BY TEMPERATURE RANGE, 2024 (% SHARE)
  169.   6.20 PACKAGING & TRANSPORT, BY TEMPERATURE RANGE, 2024 TO 2035 (USD Million)
  170.   6.21 PACKAGING & TRANSPORT, BY PAYLOAD CAPACITY, 2024 (% SHARE)
  171.   6.22 PACKAGING & TRANSPORT, BY PAYLOAD CAPACITY, 2024 TO 2035 (USD Million)
  172.   6.23 PACKAGING & TRANSPORT, BY USE, 2024 (% SHARE)
  173.   6.24 PACKAGING & TRANSPORT, BY USE, 2024 TO 2035 (USD Million)
  174.   6.25 PACKAGING & TRANSPORT, BY MEDICINE TYPE, 2024 (% SHARE)
  175.   6.26 PACKAGING & TRANSPORT, BY MEDICINE TYPE, 2024 TO 2035 (USD Million)
  176.   6.27 PACKAGING & TRANSPORT, BY END-USE INDUSTRY, 2024 (% SHARE)
  177.   6.28 PACKAGING & TRANSPORT, BY END-USE INDUSTRY, 2024 TO 2035 (USD Million)
  178.   6.29 BENCHMARKING OF MAJOR COMPETITORS
  179. 7 LIST OF TABLES
  180.   7.1 LIST OF ASSUMPTIONS
  181.     7.1.1
  182.   7.2 Brazil MARKET SIZE ESTIMATES; FORECAST
  183.     7.2.1 BY PRODUCT, 2025-2035 (USD Million)
  184.     7.2.2 BY TYPE, 2025-2035 (USD Million)
  185.     7.2.3 BY TEMPERATURE RANGE, 2025-2035 (USD Million)
  186.     7.2.4 BY PAYLOAD CAPACITY, 2025-2035 (USD Million)
  187.     7.2.5 BY USE, 2025-2035 (USD Million)
  188.     7.2.6 BY MEDICINE TYPE, 2025-2035 (USD Million)
  189.     7.2.7 BY END-USE INDUSTRY, 2025-2035 (USD Million)
  190.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  191.     7.3.1
  192.   7.4 ACQUISITION/PARTNERSHIP
  193.     7.4.1

Brazil Packaging & Transport Market Segmentation

Packaging & Transport By Product (USD Million, 2025-2035)

  • Shippers
  • Containers

Packaging & Transport By Type (USD Million, 2025-2035)

  • Active System
  • Passive System

Packaging & Transport By Temperature Range (USD Million, 2025-2035)

  • -20°C and Below
  • -20°C to 0°C
  • 2°C to 8°C
  • 8°C to 25°C
  • Above 25°C

Packaging & Transport By Payload Capacity (USD Million, 2025-2035)

  • Up to 10 L
  • 10 L - 20 L
  • 20 L - 40 L
  • 40 L - 150 L
  • Above 150 L

Packaging & Transport By Use (USD Million, 2025-2035)

  • Single Use
  • Reusable

Packaging & Transport By Medicine Type (USD Million, 2025-2035)

  • Temperature Sensitive Pharmaceutical Drugs
  • Vaccine
  • Regenerative Medicine

Packaging & Transport By End-use Industry (USD Million, 2025-2035)

  • Pharmaceuticals
  • Clinical Trials

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓